Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Arrhythmia in Hemodialysis Patients

NCT: NCT04036695 · ACTIVE_NOT_RECRUITING

NCT IDNCT04036695
StatusACTIVE_NOT_RECRUITING
Start Date2019-10-17
Completion2026-12-30

Brief Summary

Patients receiving dialysis for kidney failure suffer from very high rates of sudden cardiac death due to abnormal heart rhythms and perfusion defects associated with HD treatment. It has previously been recognized that patients suffer heart injury during the dialysis procedure which may be an important factor for investigation. The study uses a simple implantable device that can monitor heart rhythms over time to gather information on the type of abnormal rhythms that occur in dialysis patients. This information will be combined with ultrasound and x-ray scans of the heart that will also be collected. The goal is to understand the relationship between the abnormal rhythms and injury to the heart during dialysis and what causes these injuries. The information gathered in this study will be used to compare the accuracy of an in house personalized computational model to predict potential cardiac injuries when patients undergo HD treatment.

Frequently Asked Questions

What is Arrhythmia in Hemodialysis Patients?

Arrhythmia in Hemodialysis Patients is a clinical trial registered under NCT04036695. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04036695?

The current status of NCT04036695 (Arrhythmia in Hemodialysis Patients) is: ACTIVE_NOT_RECRUITING.

When did Arrhythmia in Hemodialysis Patients start?

Arrhythmia in Hemodialysis Patients started on 2019-10-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.